P017 WPSS versus Simplified Myelodysplastic Syndrome Risk Score: which is the best tool for prediction of survival in myelodysplastic patients?

M. Breccia; R. Latagliata; L. Cannella; F. Gioiosa; A. Fama; C. Stefanizzi; F. Vincenzo; C. Mercanti; M. Santopietro; G. Alimena

doi:10.1016/S0145-2126(09)70097-9

P017 WPSS versus Simplified Myelodysplastic Syndrome Risk Score: which is the best tool for prediction of survival in myelodysplastic patients?

M. Breccia, R. Latagliata, L. Cannella, F. Gioiosa, A. Fama, C. Stefanizzi, F. Vincenzo, C. Mercanti, M. Santopietro, G. Alimena

A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Leukemia Research
Volume	33
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/S0145-2126(09)70097-9
Publication status	Published - May 2009

ASJC Scopus subject areas

Cancer Research
Hematology
Oncology

Access to Document

10.1016/S0145-2126(09)70097-9

Cite this

Breccia, M., Latagliata, R., Cannella, L., Gioiosa, F., Fama, A., Stefanizzi, C., Vincenzo, F., Mercanti, C., Santopietro, M., & Alimena, G. (2009). P017 WPSS versus Simplified Myelodysplastic Syndrome Risk Score: which is the best tool for prediction of survival in myelodysplastic patients? Leukemia Research, 33(SUPPL. 1). https://doi.org/10.1016/S0145-2126(09)70097-9

P017 WPSS versus Simplified Myelodysplastic Syndrome Risk Score : which is the best tool for prediction of survival in myelodysplastic patients? / Breccia, M.; Latagliata, R.; Cannella, L.; Gioiosa, F.; Fama, A.; Stefanizzi, C.; Vincenzo, F.; Mercanti, C.; Santopietro, M.; Alimena, G.

In: Leukemia Research, Vol. 33, No. SUPPL. 1, 05.2009.

Research output: Contribution to journal › Article › peer-review

Breccia, M, Latagliata, R, Cannella, L, Gioiosa, F, Fama, A, Stefanizzi, C, Vincenzo, F, Mercanti, C, Santopietro, M & Alimena, G 2009, 'P017 WPSS versus Simplified Myelodysplastic Syndrome Risk Score: which is the best tool for prediction of survival in myelodysplastic patients?', Leukemia Research, vol. 33, no. SUPPL. 1. https://doi.org/10.1016/S0145-2126(09)70097-9

@article{dd4d4003da9c486eab215000f67977a4,

title = "P017 WPSS versus Simplified Myelodysplastic Syndrome Risk Score: which is the best tool for prediction of survival in myelodysplastic patients?",

author = "M. Breccia and R. Latagliata and L. Cannella and F. Gioiosa and A. Fama and C. Stefanizzi and F. Vincenzo and C. Mercanti and M. Santopietro and G. Alimena",

year = "2009",

month = may,

doi = "10.1016/S0145-2126(09)70097-9",

language = "English",

volume = "33",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

number = "SUPPL. 1",

}

TY - JOUR

T1 - P017 WPSS versus Simplified Myelodysplastic Syndrome Risk Score

T2 - which is the best tool for prediction of survival in myelodysplastic patients?

AU - Breccia, M.

AU - Latagliata, R.

AU - Cannella, L.

AU - Gioiosa, F.

AU - Fama, A.

AU - Stefanizzi, C.

AU - Vincenzo, F.

AU - Mercanti, C.

AU - Santopietro, M.

AU - Alimena, G.

PY - 2009/5

Y1 - 2009/5

UR - http://www.scopus.com/inward/record.url?scp=65349092851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349092851&partnerID=8YFLogxK

U2 - 10.1016/S0145-2126(09)70097-9

DO - 10.1016/S0145-2126(09)70097-9

M3 - Article

AN - SCOPUS:65349092851

VL - 33

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - SUPPL. 1

ER -

P017 WPSS versus Simplified Myelodysplastic Syndrome Risk Score: which is the best tool for prediction of survival in myelodysplastic patients?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this